Haller, Julia A

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet

Retinal Development and DisordersVirus-based gene therapy research

Cited by 1,952

Five-year safety and performance results from the argus II retinal prosthesis system clinical trial.

da Cruz, L., Dorn, J. D., Humayun, M. S., Dagnelie, G., Handa, J., Barale, P.-O., Sahel, J.-A., Stanga, P. E., Hafezi, F., Safran, A. B., et al. (2016) · Ophthalmology

Neuroscience and Neural EngineeringRetinal Development and Disorders

Cited by 359

Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy

Newman, N. J., Yu-Wai-Man, P., Subramanian, P. S., Moster, M. L., Wang, A.-G., Donahue, S. P., Leroy, B. P., Carelli, V., Biousse, V., Vignal-Clermont, C., et al. (2023) · Brain

Virus-based gene therapy researchGlaucoma and retinal disorders

Cited by 87

Serum zinc and serum lipid profiles in 778 adults

Hiller, R., Seigel, D., Sperduto, R. D., Blair, N., Burton, T. C., Farber, M. D., Gragoudas, E. S., Gunter, E. W., Haller, J., Seddon, J. M., et al. (1995) · Annals of Epidemiology

Trace Elements in HealthHeavy Metal Exposure and Toxicity

Cited by 28